The rapid development of the powerful new CRISPR-Cas9 gene-editing technology raises as many questions as it answers. Now a group of leading research organisations has thrown open the discussion to public debate. Is it now time, they ask, to the use these techniques to treat patients by altering the genes of reproductive cells and embryos to tackle genetic disease?
Full story
Technology Law Update, 2nd September 2015
Source: www.technology-law-blog.co.uk
